Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Clinical trial NCT01691872 · WITHDRAWN

Trial details

NCT number: NCT01691872
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Epilepsy, Partial

Start date: 2012-10-10
Primary completion: 2012-10-18
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.